Fabio Rocha Formiga graduated in pharmaceutical sciences, obtaininghis bachelor’s degree in 2004 from the Federal University of Rio Grande doNorte, Brazil, where he also concluded a master’s course in health sciences.In 2011, he obtained a PhD in pharmaceutical technology from the Universityof Navarra in Spain, with distinctions, as a MAEC-AECID scholar. In 2018,he completed a research training in nanobiomaterials at the Rice University(Houston, United States). Dr. Formiga has worked as a visiting professor atthe University of Coimbra, Portugal. He has experience in teaching/supervisionat the BSc, MSc, and PhD levels. In addition, he has acted as referee fornational and foreign funding agencies. He has participated as a member of universitycommittees, examination boards, and has organized scientific meetings,including the 22nd International Symposium on Microencapsulation (Chair).Dr. Formiga has also been strongly involved in collaborative programs for exchangewith European universities (from Portugal, Spain, and Denmark). He isa cofounder and vice-president of the Brazilian Chapter of Controlled ReleaseSociety (CRS, 2019–present) and guest associate editor of the Drug Deliveryand Translational Research (Springer) and Pharmaceutical Nanotechnology(Bentham). He is a member of the Brazilian Association of PharmaceuticalSciences (ABCF) and the European Foundation for Clinical Nanomedicine(CLINAM). Currently, Dr. Formiga is a research scientist and deputy head ofthe Department of Immunology at the Aggeu Magalhães Institute, OswaldoCruz Foundation (FIOCRUZ), Brazil. He also holds a tenured adjunct professorposition at University of Pernambuco (UPE). Dr. Formiga was acknowledgedwith the Research Award from Spanish Society of Pharmaceutics andPharmaceutical Technology (SEFIG) in 2013 and the Benjamin Gilbert Award from FIOCRUZ in 2017. His research has focused on pharmaceutics, drug delivery,nanotechnology, and biomaterials toward neglected tropical diseases andregenerative medicine.